$1.00
-0.03-2.91%
At close: -
$1.05
0.055.00%
After Hours: 6:03 PM EDT
Comments
Loading...
Aytu BioPharma Earnings Estimates, EPS & Revenue | NASDAQ:AYTU | Benzinga
Aytu BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS
$-0.280
Quarterly Revenue
$16.22M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$77.23M
Analyze the earnings history of Aytu BioPharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AYTU | Aytu BioPharma | -$0.52 | — | — | — | $17.99M | — | — | — | 05/14/2025 | Get Alert |
| AYTU | Aytu BioPharma | -$0.04 | $0.00 | -$0.28 | -100.00% | $22.93M | $15.55M | $16.22M | 4.32% | 02/12/2025 | Get Alert |
| AYTU | Aytu BioPharma | -$1.48 | -$0.34 | -$0.20 | 41.18% | $22.10M | $13.77M | $16.57M | 20.36% | 11/13/2024 | Get Alert |
| AYTU | Aytu BioPharma | -$0.59 | -$0.45 | -$0.82 | -82.22% | $30.73M | $18.30M | $17.98M | -1.77% | 09/26/2024 | Get Alert |
| AYTU | Aytu BioPharma | -$1.93 | -$0.64 | -$0.52 | 18.75% | $22.73M | $17.35M | $17.99M | 3.71% | 05/15/2024 | Get Alert |
| AYTU | Aytu BioPharma | -$2.15 | -$0.25 | -$0.04 | 84.00% | $26.28M | $21.75M | $22.93M | 5.47% | 02/14/2024 | Get Alert |
| AYTU | Aytu BioPharma | -$1.20 | — | -$1.48 | — | $27.66M | $27.73M | $22.10M | -20.31% | 11/14/2023 | Get Alert |
| AYTU | Aytu BioPharma | -$9.80 | -$0.95 | -$0.59 | 37.89% | $27.45M | $27.69M | $30.73M | 10.99% | 09/27/2023 | Get Alert |
| AYTU | Aytu BioPharma | -$5.40 | -$0.63 | -$1.93 | -206.35% | $24.20M | $28.00M | $22.73M | -18.81% | 05/11/2023 | Get Alert |
| AYTU | Aytu BioPharma | -$8.80 | -$1.60 | -$2.15 | -34.38% | $23.13M | $26.40M | $26.28M | -0.46% | 02/21/2023 | Get Alert |
| AYTU | Aytu BioPharma | -$6.60 | -$3.60 | -$1.20 | 66.67% | $21.90M | $24.30M | $27.66M | 13.81% | 11/14/2022 | Get Alert |
| AYTU | Aytu BioPharma | -$16.20 | -$7.40 | -$9.80 | -32.43% | $23.48M | $25.50M | $27.45M | 7.64% | 09/27/2022 | Get Alert |
| AYTU | Aytu BioPharma | -$8.60 | -$8.20 | -$5.40 | 34.15% | $13.48M | $24.80M | $24.20M | -2.42% | 05/16/2022 | Get Alert |
| AYTU | Aytu BioPharma | -$14.40 | -$11.60 | -$8.80 | 24.14% | $15.15M | $27.20M | $23.13M | -14.98% | 02/14/2022 | Get Alert |
| AYTU | Aytu BioPharma | -$8.00 | -$9.80 | -$6.60 | 32.65% | $13.52M | $22.10M | $21.90M | -0.92% | 11/15/2021 | Get Alert |
| AYTU | Aytu BioPharma | -$4.00 | -$9.80 | -$16.20 | -65.31% | $14.86M | $20.90M | $23.48M | 12.35% | 09/27/2021 | Get Alert |
| AYTU | Aytu BioPharma | -$30.00 | -$6.20 | -$8.60 | -38.71% | $8.16M | $14.06M | $13.48M | -4.11% | 05/17/2021 | Get Alert |
| AYTU | Aytu BioPharma | -$62.00 | -$8.80 | -$14.00 | -59.09% | $3.17M | $12.25M | $15.15M | 23.65% | 02/11/2021 | Get Alert |
| AYTU | Aytu BioPharma | -$64.00 | -$10.00 | -$8.00 | 20.00% | $1.44M | $13.33M | $13.52M | 1.43% | 11/12/2020 | Get Alert |
| AYTU | Aytu BioPharma | -$260.00 | -$6.00 | -$4.00 | 33.33% | $1.72M | $11.24M | $14.86M | 32.22% | 10/06/2020 | Get Alert |
| AYTU | Aytu BioPharma | -$100.00 | -$44.00 | -$30.00 | 31.82% | $2.38M | $6.40M | $8.16M | 27.44% | 05/14/2020 | Get Alert |
Aytu BioPharma (AYTU) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-02-12 | $-0.28 | $0 | -100.0 % |
| Q1 | 2024-11-13 | $-0.20 | $-0.34 | 41.2 % |
| Q4 | 2024-09-26 | $-0.82 | $-0.45 | -82.2 % |
| Q3 | 2024-05-15 | $-0.52 | $-0.64 | 18.8 % |
Aytu BioPharma (AYTU) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-02-12 | $16.22M | $15.55M | 4.32 % |
| Q1 | 2024-11-13 | $16.57M | $13.77M | 20.4 % |
| Q4 | 2024-09-26 | $17.98M | $18.30M | -1.77 % |
| Q3 | 2024-05-15 | $17.99M | $17.35M | 3.71 % |
FAQ
When is Aytu BioPharma (NASDAQ:AYTU) reporting earnings?
Aytu BioPharma (AYTU) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on February 12, 2025 for Q2.
What were the latest earnings per share (EPS) for Aytu BioPharma (NASDAQ:AYTU)?
The Actual EPS was $-0.28, which missed the estimate of $0.00.
What were Aytu BioPharma’s (NASDAQ:AYTU) revenues?
The Actual Revenue was $16.2M, which beat the estimate of $15.6M.
Browse earnings estimates, EPS, and revenue on all stocks.